Hypoxia inducible factor and microvessels in peri implantation endometrium of women with recurrent miscarriage

Wednesday, June 1, 2016
Expression of hypoxia inducible factor 1a and vascularization status in peri-implantation endometrium is altered in the nonconception cycles of women with a history of recurrent miscarriage.

Read More

The relationship between recurrent pregnancy loss and the male contribution

Sunday, May 1, 2016

Author:
Eve C. Feinberg, M.D.…

Read More

Diminished ovarian reserve Is it a neglected cause in the assessment of recurrent miscarriage A cohort study

Sunday, May 1, 2016
Diminished ovarian reserve may be a hidden cause for recurrent miscarriage regardless of maternal age.

Read More

Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization intracytoplasmic sperm injection

Tuesday, November 25, 2014
This retrospective cohort study presents the live birth rate in 52 patients with three or more previous pregnancy losses after assisted reproductive techniques who were treated with intravenous immunoglobulin and prednisone concurrent with in vitro fertilization/intracytoplasmic sperm injection.

Read More

Frequency of euploid miscarriage is increased in obese women with recurrent early pregnancy loss

Wednesday, July 30, 2014
Based on a cohort of 372 women with a history of recurrent early pregnancy loss, obesity was associated with euploid miscarriage, which is a known risk factor for subsequent miscarriage.

Read More

Gene gene interactions and risk of recurrent miscarriages in carriers of endocrine gland derived vascular endothelial growth factor and prokineticin receptor polymorphisms

Friday, June 27, 2014
Two nonsynonymous prokineticin receptor variants were significantly associated with idiopathic recurrent miscarriages, and endocrine gland–derived vascular endothelial growth factor variant has genetic interactions with two receptor genes that contribute to miscarriage risk.

Read More

Chronic endometritis in women with recurrent early pregnancy loss and or fetal demise

Monday, March 31, 2014
There was a high prevalence of chronic endometritis in a cohort of 395 women with pregnancy loss. “Test of cure” was 100% with antibiotics. Subsequent live-birth rates were encouraging.

Read More

Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss

Thursday, October 31, 2013
The high prevalence of subclinical hypothyroidism among women with recurrent early pregnancy loss did not appear to impact the live-birth rates in this population.

Read More

Effect of prior birth and miscarriage frequency on the prevalence of acquired and congenital uterine anomalies in women with recurrent miscarriage a cross sectional study

Friday, May 31, 2013
Diagnostic imaging for congenital and acquired uterine anomalies should be recommended to women after two recurrent miscarriages, even if they have had a prior live birth.

Read More

A modest but significant effect of CGB5 gene promoter polymorphisms in modulating the risk of recurrent miscarriage

Friday, May 31, 2013
CGB5 promoter variants were associated with a modest but significant effect on reducing recurrent miscarriage (RM) risk. No common genetic variants in CGB5 and CGB8 were associated with increased RM susceptibility.

Read More

Number and sequence of preceding miscarriages and maternal age for the prediction of Antiphospholipid Syndrome in women with recurrent miscarriage

Wednesday, January 2, 2013
The risk for antiphospholipid syndrome is the same after two, not necessarily consecutive, miscarriages, as for women with three or more miscarriages.

Read More

Decreased endometrial vascularity in patients with antiphospholipid antibodies associated recurrent miscarriage during midluteal phase

Thursday, November 29, 2012
We found a decrease in endometrial-subendometrial vascularity as shown by three-dimensional ultrasonography and power Doppler angiography in antiphospholipid antibodies–associated recurrent miscarriage patients during the peri-implantation period.

Read More

Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy

Friday, June 8, 2012
Thyroid peroxidase antibody does not have prognostic value regarding the outcome of a subsequent pregnancy, and empirical thyroxine therapy in those who tested positive did not seem to improve outcome.

Read More

Is chromosome testing of the second miscarriage cost- saving: A decision analysis of selective vs. universal recurrent pregnancy loss evaluation

Thursday, June 7, 2012
Selective recurrent pregnancy loss (RPL) evaluation, which is based upon chromosome testing of the second miscarriage, is a cost-saving strategy for couples with RPL when compared with universal RPL evaluation.

Read More

Translate »